Sentinel lymph node biopsy in breast cancer: A history and current clinical recommendations

Surgical Oncology

Volumn 21, Issue 3, 2012, Pages 196-200

  DAngelo Donovan, Desiree D ^a   Dickson Witmer, Diana ^b   Petrelli, Nicholas J ^b  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b HELEN F GRAHAM CANCER CENTER   (United States)

Author keywords

Breast cancer; Sentinel lypmh node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FOLLOW UP; HISTORY OF MEDICINE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHATIC SYSTEM; OVERALL SURVIVAL; PAROTIDECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS;

BREAST NEOPLASMS; FEMALE; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY;

EID: 84859052745     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2011.12.005     Document Type: Review

References (42)

1. D.N. Krag, D. Weaver, A. Takamaure, T. Ashikaga, F. Moffat, and S.V. Klimberg The sentinel node in breast cancer: a multicenter validation study N Engl J Med 339 14 1998 941 946
2. J.T. Pieter, O. Nieweg, R. Valdés Olmos, E.J. Rutgers, and B. Kroon History of sentinel node and validation of the technique Breast Cancer Res 3 2001 109 112
3. R.K. Gilchrist Fundamental factors governing lymphatic spread of carcinoma Ann Surg 111 1940 630 639
4. I. Zeidman, and J.M. Buss Experimental studies of the spread of cancer in the lymphatic system Cancer Res 14 1954 403 405
5. E.A. Gould, T. Winship, P.H. Philbin, and H.H. Kerr Observations on a 'sentinel node' in cancer of the parotid Cancer 13 1960 77 78
6. R.M. Cabañas An approach for the treatment of penile carcinoma Cancer 39 1977 456 466
7. D.L. Morton, D.R. Wen, J.H. Wong, J.S. Economou, L.A. Cagle, and F.K. Storm Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
8. Morton DL, Wen DR, Cochran AJ. Pathophysiology of regional lymph node metastases in early melanoma studied by intraoperative mapping of the cutaneous lymphatics [abstract]. Second International Conference on Melanoma. 1989:131.
9. A.E. Giuliano, D.M. Kirgan, J.M. Guenther, and D.L. Morton Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 1994 391 398
10. D.N. Krag, D.L. Weaver, J.C. Alex, and J.T. Fairbank Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe Surg Oncol 2 1993 335 340
11. D.N. Krag, S. Harlow, D. Weaver, and T. Ashikaga Radiolabeled sentinel node biopsy: collaborative trial with The National Cancer Institute World J Surg 25 2001 823 828
12. K.M. McMasters, T.M. Tuttle, D.J. Carlson, C.M. Brown, R.D. Noyes, and R.L. Glasser Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J Clin Oncol 18 13 2000 2560 2566
13. K.M. McMasters, S.L. Wong, R.C.G. Martin, C. Chao, T.M. Tuttle, and R.D. Noyes Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi institutional study Ann Surg 233 5 2001 676 687
14. R.L. White, and L.G. Wilke Update on the NSABP and ACOSOG breast cancer sentinel node trials Am Surg 70 5 2004 420 424
15. D.N. Krag, T.B. Julian, S.P. Harlow, D.L. Weaver, T. Ashikaga, and J. Bryant NSABP-32: phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial Ann Surg Oncol 11 3 2003 208S 210S
16. D.N. Krag, S.J. Anderson, T.B. Julian, A.M. Brown, S.P. Harlow, and T. Ashikaga Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP-32 randomized phase III trial Lancet Oncol 8 2007 881 888
17. D.N. Krag, S.J. Anderson, T.B. Julian, A.M. Brown, S.P. Harlow, and J.P. Constantino Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival finding from the NSABP-32 randomized phase III trail Lancet Oncol 11 2010 927 933
18. U. Veronesi, P. Giovanni, G. Viale, A. Luini, S. Zurrida, and V. Galimberti A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 2003 546 553
19. A.D. Purushotham, S. Upponi, M.B. Klevesath, L. Bobrow, K. Millar, and J.P. Myles Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trail J Clin Oncol 23 2005 4312 4321
20. R.E. Mansel, L. Fallowfield, M. Kissin, A. Goyal, R.G. Newcombe, and J.M. Dixon Randomized multicenter trail of sentinel node biopsy versus standard axially treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst 98 9 2006 599 608
21. H.S. Cody Clinical significance and management of extra-axillary sentinel lymph nodes: worthwhile or irrelevant? Surg Oncol Clin N Am 19 2010 507 517
22. B. Fisher, C. Redmond, and E. Fisher Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation N Engl J Med 312 1985 674 681
23. E.E. Harris, W.T. Hwang, F. Seyednejad, and L.J. Solin Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy Cancer 98 2003 2144 2151
24. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC cancer staging handbook 7th ed. 2010 American Joint Committee on Cancer Chicago, IL Ch. 32 Breast
25. A.M. Neville, K.N. Price, R.D. Gelber, and A. Goldhirsch Axillary node micrometastases and breast cancer Lancet 337 8749 1991 1110
26. R.J. Cote, H.F. Peterson, B. Chaiwun, R.D. Gelber, A. Goldhirsch, and M. Castiglione-Gertsch Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group Lancet 354 9182 1999 896 900
27. J. Reed, M. Rosman, K.M. Verbanac, A. Mannie, Z. Cheng, and L. Tafra Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer:10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center sentinel node multicenter study J Am Coll Surg 208 2009 333 340
28. A.B. Chagpar Clinical significance of minimal sentinel node involvement and management options Surg Oncol Clin N Am 194 2010 493 505
29. M.S. Sabel Sentinel lymph node biopsy before or after neoadjuvant chemotherapy: pros and cons Surg Oncol Clin N Am 19 2010 519 538
30. M.E. Straver, E.J.T. Rutgers, N.S. Russel, H.S.A. Oldenburg, S. Rodenhuis, and J. Wesseling Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer Eur J Cancer 45 2009 2284 2292
31. R. Rouzier, J.-M. Extra, J. Klijanienko, M.-C. Falcou, B. Asselain, and A. Vincent-Salomon Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes J Clin Oncol 20 5 2002 1304 1310
32. E.A. Newman, M.S. Sabel, A.V. Nees, A. Schott, K.M. Diehl, and V.M. Cimmino Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation Ann Surg Oncol 14 10 2007 2946 2952
33. B.T. Hennessy, G.N. Hortobagyi, R. Rouzier, H. Kuerer, N. Sneigel, and A. Buzdar Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy J Clin Oncol 23 36 2005 9304 9311
34. J.D. Beatty, L.M. Precht, K. Lowe, and M. Atwood Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer Am J Surg 197 2009 637 642
35. E.P. Mamounas, A. Brown, S. Anderson, R. Smith, T. Julian, and B. Miller Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27 J Clin Oncol 23 2005 2694 2702
36. Y. Xing, M. Foy, D.D. Cox, H.M. Kuerer, K.K. Hunt, and J.N. Cormier Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer Br J Surg 93 2006 539 546
37. A.E. Giuliano, K.K. Hunt, K.V. Ballman, P.D. Beitsch, P.W. Whitworth, and P.W. Blumencranz Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized trial JAMA 305 6 2011 569 575
38. B. Fisher, C. Redmond, E.R. Fisher, M. Bauer, N. Wolmark, and D.L. Wickerman Ten-year results of a randomized clinical trail comparing radical mastectomy and total mastectomy with or without radiation N Engl J Med 312 1985 674 681
39. G. Martielli, R. Miceli, M.G. Daidone, G. Vetrella, A.M. Cerrotta, and D. Piromalli Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up Ann Surg Oncol 18 2011 123 133
40. M. Greco, R. Agresti, N. Cascinelli, P. Casalini, R. Giovanazzi, and A. Maucione Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis Ann Surg 232 2000 1 7
41. M. Morrow, and A.E. Giuliano To cut is to cure: can we really apply Z11 in practice? Ann Surg Oncol 18 2011 2413 2415
42. I.S. Grills, L.L. Kestin, N. Golstein, C. Mitchell, A. Martinez, and J. Ingold Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes Int J Radiat Oncol Biol Phys 56 2003 658 670